In-vitro culture method for T lymphocytes
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- LIAONING MEDI BIOTECH CO LTD
- Publication Date
- 2012-05-02
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a method for treating mononuclear cells in human peripheral blood, umbilical cord blood, pleural effusion, ascites and other samples to become cytokine-induced killer cells (Cytokine-Induced Killer, referred to as CIK), especially a method for The method for culturing T lymphocytes in vitro can be applied to clinical cell biotherapy, basic medical research, clinical application research and biotechnology research, especially immune system research and tumor killing effect research. Background technique
[0002] As tumors pose an increasingly serious threat to human survival and health, the treatment models for tumors are also changing rapidly. Various new drugs, new technologies, and new methods emerge in an endless stream. Among them, cell biology therapy is developed after surgery, radiotherapy, and chemotherapy. The fourth type of tumor treatment method has become an important development direction in tumor biologica...